No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Actinogen Medical Expects Results From XanaCIDD Phase 2a Clinical Trial in August; Shares Down 6%
Actinogen's Xanamem Could Slow Alzheimer's Progress, New Biomarker Trial Reveals
Stocks of the Hour: Actinogen Medical, De Grey Mining, Cooper Metals
Actinogen Medical Completes AU$3.9 Million Non-Renounceable Entitlement Offer
Actinogen Medical Opens AU$3.9 Million Entitlement Offer; Shares Down 7%
Actinogen Medical Lodges Prospectus for Nearly AU$4 Million Entitlement Offer
No Data